Market Cap

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd Market Capitalization:

CN¥22.57 Billion

CNY as of Jan. 1, 2024

US$3.17 Billion

business Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd Company Profile

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd Main Stock Listing

SSE: 603707

Market Capitalization History of Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥22.57 B -23.44%
Jan. 1, 2023 CN¥29.48 B -50.06%
Jan. 1, 2022 CN¥59.02 B 46.98%
Jan. 1, 2021 CN¥40.16 B -16.37%
Jan. 1, 2020 CN¥48.01 B 232.79%
Jan. 1, 2019 CN¥14.43 B -7.17%
Jan. 1, 2018 CN¥15.54 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603707

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.